Helicobacter pylori. Peptic ulcer, site unspecified
Conditions
Interventions
Intervention 1: intervention 1 group : daily 2 gr morEPA supplement during 12 weeks. Intervention 2: intervention 2 group : daily 2 gr morDHA supplement during 12 weeks. Intervention 3: control group
Treatment - Drugs
intervention 1 group : daily 2 gr morEPA supplement during 12 weeks
intervention 2 group : daily 2 gr morDHA supplement during 12 weeks
control group : daily 2 gr MCT placebo during 12 weeks
Sponsors
Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC)
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: positive helicobacter pylori test result; no history of pharmaceutical treatment for infection eradication; no gastric surgery; no history of peptic ulcer; no any disease that cause inflammation & increase of serum inflammatory markers level such as diabetes, CVD, respiratoryinflammations such as asthma,...; no consumption of any drug other than prescribed drugs during the study; no consumption of antibiotic or bismut during 2 months before the trial; no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial; no consumption of omega-3 supplements at least 3 months before the trial; no smoking; BMI less than 30; age between 20-60 years old; leaning to cooperation Exclusion criteria: no leaning to continuing the cooperation; any change in type or dose of prescribed drugs; any change in daily diet or physical activity; consumption of any antioxidant supplement; consumption of less than 70% of supplements given to patients at the start of the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry.;LDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry.;HDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry.;TG. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: colorimetry.;TNF-alfa. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Farzad Shidfar
School of Public Health of Tehran University of Medical Sciences
Outcome results
None listed